Amphetamine was Able to Trigger The Risk of Parkinson’s Disease. Parkinson’s disease is a disease that attacks the nervous system. People suffering from this disease experience tremors. and most of these diseases experienced by older people. But it is not possible the person who was 40 or earlier can also suffer from this disease. Recently, based on research, amphetamines may increase the risk for Parkinson’s disease.
New research shows people who have used amphetamines such as Benzedrine and dexedrine tend to increase the risk of Parkinson’s disease, according to a study released Sunday (20 / 2) which will be presented at the 63rd annual meeting of the American Academy of Neurology in Honolulu, 9-16 April 2011.
Amphetamine Benzedrine and dexedrine is often prescribed to increase awareness and focus for people with less attention hyperactivity disorder and narcolepsy, a disorder that can cause excessive sleepiness during the day and sleep attacks sudden. The drug is also used to treat traumatic brain injury.
The study involved 66,348 people in Northern California who participated in the Multiphasic Health Examination between 1964 and 1973 and evaluated again in 1995. The average age of participants at the beginning of this study was 36 years old. Of all participants, 1154 people have been diagnosed with Parkinson’s disease at the end of the study.
Amphetamine exposure is determined by the use of drugs to lose weight and whether the frequent use of Benzedrine or dexedrine. Amphetamines are among the drugs commonly used to lose weight.
According to studies, people who reported using Benzedrine or dexedrine almost 60 percent more likely to increase the risk of Parkinson’s than those who do not use traditional medicine. There was no increased risk found in people who use drugs to lose weight.
“If further studies confirm these findings, the potential increased risk of Parkinson’s disease from amphetamine should be considered when doctors prescribe these drugs as well as prohibit the abuse of this drug,” said Stephen K. Van Den Eeden, PhD, Division of Research Kaiser Permanente Northern California in Oakland, California.
Van Den Eeden explained that amphetamines affect dopamine release and retrieval, a key neurotransmitter involved in Parkinson’s disease. He explained that further research is necessary to continue to learn more about the mechanism.
The cause of Parkinson’s disease is not known. However, research has shown, that amphetamine was able to trigger the risk of Parkinson’s disease.